Seeking Alpha

Pozen (POZN +21.2%) shares spike after the FDA approves its new Vimovo arthritis medication...

Pozen (POZN +21.2%) shares spike after the FDA approves its new Vimovo arthritis medication co-developed with AstraZeneca (AZN +0.3%).
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)